AI-CVD-AF:冠動脈石灰化スキャンに基づく新規心房細動予測モデル
Seyed Reza Mirjalili1, Kyle Atlas1, Anthony P Reeves2
1HeartLung.AI, Houston, TX, 77021, USA.
Aims:
The AI-CVD initiative seeks to extract actionable insights from coronary artery calcium (CAC) scans beyond the traditional CAC score. We previously demonstrated that AI-derived cardiac chamber volumes from CAC scans predict incident heart failure (HF). We aimed to evaluate whether left-to-right cardiac chamber volume ratios outperform chamber volumes in predicting HF.
Method And Results:
We used AI-CVD cardiac chambers volumetry data from CAC scans of 5,732 asymptomatic Multi-Ethnic Study of Atherosclerosis (MESA) participants (age 62.2±10.3 years; 47.7% male). Left-to-right ventricular (LV/RV), atrial (LA/RA), and left atrial-to-right ventricular (LA/RV) volume ratios were evaluated using multivariable Cox models and feature selection techniques. External validation was performed in the Framingham Heart Study Offspring (FHS-O) cohort (N=1,052, age:58.3±8.3, 42.9% male). During a median follow-up of 17.7 years in MESA, 369 participants (6.3%) developed HF. Elevated ratios (≥75th & ≥95th percentile) of LV/RV, LA/RA, and LA/RV were strongly associated with incident HF: hazard ratio (HR) for ≥95th percentile were 4.04 (95% CI:2.89-5.65), 2.90 (95% CI:2.07-4.06), and 2.61 (95% CI:1.87-3.46), respectively. Among participants with normal LV sizes (interquartile-range), LV/RV ≥95th significantly predicted HF (HR:2.34; 95% CI:1.29-4.25). In FHS-O (median follow-up 14.4 years), 56 HF events (5.3%) occurred. LV/RV ≥75th percentile was significantly associated with HF (HR:2.23; 95% CI:1.16-4.30), whereas LA/RA was not (HR:1.22; 95% CI:0.65-2.29). Feature selection techniques identified LV/RV as the strongest predictor.
Conclusion:
In these two prospective cohorts, AI-derived LV/RV ratio from CAC scans strongly predicted HF. New clinical trials guided by these imaging biomarkers are warranted to establish their clinical utility.
関連する概念動画
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations


